AI Rx - Drugs: A boon or a bane
Details
HOW TO JOIN THIS WEBINAR :-
Welcome to "AI Rx - Accelerating Drug Discovery with Gen AI - Project Series".
Learn how Gen AI and LLMs are accelerating the complex process of Drug Discovery whether it is designing novel proteins, generative molecular sequences, predicting molecule properties and lot more..
This is Project 2 Webinar for this Series. You can see program details and enroll here..
There are two versions of this Program :
1) Free Live Webinars : Live Project Webinars are presented FREE every other Saturday starting Nov 16th via Webinars on this page. This is the 2nd WEBINAR in this series.
2) Paid Program with Certification and Projects : You can get webinar recordings, project notebooks and certification for a fee of USD 29.99. You can enroll on the program page. (OR pay here payment link)
Live Webinar Link (Open to All) : https://meet.google.com/dxd-oshj-swy
ABOUT THIS PROJECT WEBINAR :-
Topic :- AI Rx - Drugs: A boon or a bane
Presenter - Indrajit Singh, Engineering Director, CellStrat AI Lab
This Project will cover introduction to molecules, SMILES notation for molecules and using Transformers to generate SMILE Strings that represent potentially drug-like molecules.
Check out past Webinars on CellStrat YOUTUBE channel..
SIGN UP FOR CELLBOT - A WORLD-CLASS HEALTH SEARCH ENGINE USING GENERATIVE AI
Introducing CellBot — a world-class Health Search Engine that uses state of the art Generative AI. CellBot answers any questions on health and pharma that you might have.
Just chose a health or pharma topic and within 30 seconds, a powerful Chatbot appears. Then you can ask any questions on that topic to get accurate answers for your questions.
CellBot is trained on leading health data repositories of the world. It uses state of the art LLMs for mining this data.
Try CellBot today and solve for your health or pharma enquiries..
QUESTIONS OR COMMENTS — contact Team CellStrat at phone or whatsapp no +91-9742800566 or email [email protected].
AI Rx - Drugs: A boon or a bane